BRAMMER BIO
Brammer Bio is a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize cell and gene therapies. With an experienced management team and exceptional scientific expertise and proven manufacturing capabilities we offer the knowledge and resources necessary to help you deliver innovative cell and gene-based therapies. Brammer Bio is focused on providing clinical and commercial supply of autologous and allogeneic cell therapies, and viral... vector products for in vivo and ex vivo therapeutic applications. Along with process and analytical development and regulatory support we enable large pharma and biotech clients to accelerate the delivery of novel medicines and improve patient health. Brammer Bio occupies 45,000 ft2 of process development and phase I/II clinical manufacturing space in Alachua, FL, and is developing a 50,000 ft2 facility in Lexington, MA, with plans to build-out large-scale, phase III/commercial ready viral vector manufacturing suites, segregated cell and gene therapy suites, and QC and analytical laboratories for clinical and commercial launch services.
BRAMMER BIO
Industry:
Biotechnology Genetics Health Care Manufacturing Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.brammerbio.com
Total Employee:
251+
Status:
Active
Contact:
(386)418-8199
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Domain Not Resolving IPv6 Google Maps Microsoft Azure DNS Microsoft GoDaddy SSL MailChimp SPF Mimecast Proofpoint
Similar Organizations
BioCentriq
BioCentriq is the cell and gene therapy development and manufacturing center.
Biomeva
BIOMEVA GmbH is an experienced and highly reliable contract manufacturing organization.
California Stem Cell
California Stem Cell focuses on manufacturing high-purity human cells for therapeutic development and clinical applications.
Genopis
Genopis specializes in plasmid DNA based technology and provides contract development and manufacturing organization (CDMO) opportunities
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-03-31 | Florida Biologix | Florida Biologix acquired by Brammer Bio | 1.7 B USD |
Investors List
Ampersand Capital Partners
Ampersand Capital Partners investment in Private Equity Round - Brammer Bio
Newest Events participated
Participated in Gene Therapy for Rare Disorders 2017
on 2017-04-24 as sponsor
Official Site Inspections
http://www.brammerbio.com
- Host name: 208.89.142.141
- IP address: 208.89.142.141
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Brammer Bio"
Brammer Bio - LinkedIn
Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies.See details»
Thermo Fisher Scientific to Acquire Brammer Bio, a …
Mar 24, 2019 Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene …See details»
Brammer Bio - Crunchbase Company Profile & Funding
Brammer Bio is a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize cell and gene therapies. ... Brammer Bio occupies 45,000 ft2 of process development and …See details»
Thermo Fisher Scientific to Acquire Brammer Bio, a …
Mar 25, 2019 Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the ...See details»
Brammer Bio Information - RocketReach
Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies. ...See details»
Thermo Fisher Scientific Completes Acquisition of …
May 1, 2019 Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene …See details»
Brammer Bio Company Profile - Office Locations, Competitors
Brammer Bio is a viral vector contract development and manufacturing organization for companies developing gene-modified cell therapies and in vivo gene therapies. It delivers a …See details»
Brammer Bio, a Leader in Viral Vector Manufacturing, to be …
Mar 26, 2019 Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to …See details»
Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip
Mar 25, 2019 Brammer Bio is a viral vector contract development and manufacturing organization (CDMO). The company with its services enables the biopharma customers to …See details»
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in ... - IBO
Mar 25, 2019 Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to …See details»
Thermo Fisher's Brammer Bio Completing $100M in …
Jun 14, 2019 Thermo Fisher Scientific says its recently-acquired Brammer Bio is completing $100 million in capital expansion projects, as the viral vector contract development and manufacturing organization ...See details»
Brammer Bio Company Profile 2024: Valuation, Investors
Brammer Bio General Information Description. Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides clinical and commercial …See details»
Brammer Bio Expands Leadership Team for Commercial Readiness
CAMBRIDGE, Mass., March 20, 2018 /PRNewswire/ — Brammer Bio ("Brammer"), a best-in-class viral vector contract development and manufacturing organization (CDMO) for …See details»
Brammer Bolsters Leadership Team and Announces Chief Quality …
CAMBRIDGE, Mass., Jan. 3, 2019 /PRNewswire/ -- Brammer Bio ("Brammer"), a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies …See details»
Brammer Bio Launches Gene Therapy Product Manufacturing …
CAMBRIDGE, Mass., Nov. 27, 2017 /PRNewswire/ -- Brammer Bio ("Brammer"), a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO), today …See details»
Brammer Bolsters Leadership Team and Announces Chief Quality …
Jan 3, 2019 Brammer Bio ("Brammer"), a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies …See details»
Brammer Bio - Facebook
Brammer Bio. 188 likes. Brammer Bio is an experienced contract development manufacturing organizationSee details»
Brammer Bio Announces Major Milestone in Establishing …
CAMBRIDGE, Mass., May 9, 2017 /PRNewswire/ -- Brammer Bio ("Brammer"), a cell and gene therapy contract development and manufacturing organization (CDMO), today announced that …See details»
Brammer Bio announces progress on $200 million program to …
CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- Brammer Bio ("Brammer"), a best-in-class viral vector contract development and manufacturing organization (CDMO), announces that a …See details»